Gast ::
| Hauptseite > Publikationsdatenbank > Noninvasive imaging of endogenus neural stem cell mobilization in vivo using positron emission tomography |
| Hauptseite > Publikationsdatenbank > Noninvasive imaging of endogenus neural stem cell mobilization in vivo using positron emission tomography |
| Journal Article | PreJuSER-9719 |
; ; ; ; ; ; ; ; ; ;
2010
Soc.
Washington, DC
This record in other databases: 
Please use a persistent id in citations: http://hdl.handle.net/2128/20585 doi:10.1523/JNEUROSCI.6092-09.2010
Abstract: Neural stem cells reside in two major niches in the adult brain [i.e., the subventricular zone (SVZ) and the dentate gyrus of the hippocampus]. Insults to the brain such as cerebral ischemia result in a physiological mobilization of endogenous neural stem cells. Since recent studies showed that pharmacological stimulation can be used to expand the endogenous neural stem cell niche, hope has been raised to enhance the brain's own regenerative capacity. For the evaluation of such novel therapeutic approaches, longitudinal and intraindividual monitoring of the endogenous neural stem cell niche would be required. However, to date no conclusive imaging technique has been established. We used positron emission tomography (PET) and the radiotracer 3'-deoxy-3'-[(18)F]fluoro-l-thymidine ([(18)F]FLT) that enables imaging and measuring of proliferation to noninvasively detect endogenous neural stem cells in the normal and diseased adult rat brain in vivo. This method indeed visualized neural stem cell niches in the living rat brain, identified as increased [(18)F]FLT-binding in the SVZ and the hippocampus. Focal cerebral ischemia and subsequent damage of the blood-brain barrier did not interfere with the capability of [(18)F]FLT-PET to visualize neural stem cell mobilization. Moreover, [(18)F]FLT-PET allowed for an in vivo quantification of increased neural stem cell mobilization caused by pharmacological stimulation or by focal cerebral ischemia. The data suggest that noninvasive longitudinal monitoring and quantification of endogenous neural stem cell activation in the brain is feasible and that [(18)F]FLT-PET could be used to monitor the effects of drugs aimed at expanding the neural stem cell niche.
Keyword(s): Animals (MeSH) ; Brain: drug effects (MeSH) ; Brain: embryology (MeSH) ; Brain: metabolism (MeSH) ; Brain: physiology (MeSH) ; Brain: radionuclide imaging (MeSH) ; Brain Ischemia: metabolism (MeSH) ; Brain Ischemia: physiopathology (MeSH) ; Cell Movement: drug effects (MeSH) ; Cell Movement: physiology (MeSH) ; Cell Proliferation: drug effects (MeSH) ; Cells, Cultured (MeSH) ; Dideoxynucleosides: metabolism (MeSH) ; Fibroblast Growth Factor 2: pharmacology (MeSH) ; Insulin: pharmacology (MeSH) ; Intracellular Signaling Peptides and Proteins (MeSH) ; Lateral Ventricles: drug effects (MeSH) ; Lateral Ventricles: physiology (MeSH) ; Membrane Proteins: pharmacology (MeSH) ; Neurons: metabolism (MeSH) ; Neurons: physiology (MeSH) ; Positron-Emission Tomography: methods (MeSH) ; Rats (MeSH) ; Stem Cells: metabolism (MeSH) ; Stem Cells: physiology (MeSH) ; Dideoxynucleosides ; Insulin ; Intracellular Signaling Peptides and Proteins ; Membrane Proteins ; delta protein ; Fibroblast Growth Factor 2 ; alovudine ; J
|
The record appears in these collections: |
PDF
PDF (PDFA)